Acetylcholinesterase inhibitors in Alzheimer’s disease

This publication has 48 references indexed in Scilit:

• Donepezil
  Drugs & Aging, 1997
• The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
  Dementia and Geriatric Cognitive Disorders, 1996
• The Neuropsychiatric Inventory
  Neurology, 1994
• Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compounds
  Bioorganic & Medicinal Chemistry Letters, 1992
• Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trial
  Drug Development Research, 1990
• Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects
  Drug Development Research, 1988
• Effects of Cholinergic Enhancement Therapies on Memory Function in Alzheimer's Disease: A Meta-Analysis of the Literature
  Australian & New Zealand Journal of Psychiatry, 1986
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984
• Levels of Metrifonate and Dichlorvos in Plasma and Erythrocytes during Treatment of Schistosomiasis with Bilarcil®
  Acta Pharmacologica et Toxicologica, 1981
• “Mini-mental state”
  Journal of Psychiatric Research, 1975